Lv7
4980 积分 2022-08-01 加入
Safety and efficacy of the selective tyrosine kinase 2/Janus kinase 1 inhibitor TLL-018 in moderate to severe chronic spontaneous urticaria patients with inadequate response to H1 antihistamines: a phase Ib, randomized, double-blind, placebo-controlled pilot study
11天前
已完结
Efficacy and Safety of tranexamic acid versus vitamin c after microneedling in treatment of melasma: Clinical and Dermoscopic study
12天前
已完结
XPro1595 in early Alzheimer’s disease with inflammation: results from the phase 2 MINDFuL trial
15天前
已关闭
A Phase 2 Study of Valbenazine (NBI-98854) for Treatment of Tardive Dyskinesia: KINECT 2 (S27.007)
17天前
已完结
Lecanemab in Early Alzheimer’s Disease
22天前
已完结
Clarity AD: Asian regional analysis of a phase III trial of lecanemab in early Alzheimer's disease
22天前
已完结
Population Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I and II Clinical Trials
1个月前
已完结
Evaluation of a Janus kinase 1 inhibitor, PF-04965842, in healthy subjects: A phase 1, randomized, placebo-controlled, dose-escalation study
1个月前
已完结
The emerging safety profile of JAK inhibitors in rheumatic disease
1个月前
已完结
Targeting the JAK/STAT3/SOCS signaling pathway in Alzheimer's disease
1个月前
已完结
皖公网安备34019202002308
